Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gastrointestinal tumors
Biotech
Agenus focuses on survival data as trial flops with no responses
With the study generating early evidence the cocktail improves survival, Agenus said the data support further assessment of the combination.
Nick Paul Taylor
Apr 20, 2026 5:53am
Cogent eyes FDA approval after clearing another ph. 3 hurdle
Nov 10, 2025 10:57am
Olympus forms GI robotics startup with Revival Healthcare
Jul 25, 2025 11:50am
Astellas aims for CLDN18.2 gold with $1.34B licensing deal
May 29, 2025 7:30pm
Cancer biotech Inspirna winding down
Apr 1, 2025 3:50am
ArriVent pays Lepu $47M for GI-focused preclinical ADC
Jan 22, 2025 7:15am
